ANI Pharmaceuticals, Inc. (ANIP) vs Cronos Group Inc. (CRON)
- ANI Pharmaceuticals, Inc. ANIP 72.08 −0.28%
- Cronos Group Inc. CRON 3.22 +0.63%
ANI Pharmaceuticals, Inc. and Cronos Group Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.7B against $1.2B — 1.4× the size. ANI Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 16.1×. Cronos Group Inc. grew revenue faster over the last twelve months: 37.5% against 30.9%. Cronos Group Inc. has the higher net margin (20.9% vs 11.0%) and the lower return on invested capital (−0.34% vs 11.3%). Across the 21 metrics below, ANI Pharmaceuticals, Inc. leads on 15 and Cronos Group Inc. on 6.
Valuation
Profitability
| Metric | ANIP | CRON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.40% | 45.86% | 53.94% |
| Operating margin | 15.37% | (0.96%) | 0.00% |
| Net margin | 11.04% | 20.91% | 0.00% |
| Free cash flow margin | 17.12% | 27.61% | 0.00% |
| Return on equity | 20.88% | 3.33% | (0.40%) |
| Return on assets | 7.61% | 3.18% | (3.32%) |
| Return on invested capital | 11.30% | (0.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack